W&
Williams & Novak, LLC
13F filer · CIK 0001998419Reported Jul 8, 2026
Net buyer this quarter
13F portfolio value$151MU.S. long equity reported on 13F
Positions747 new · 11 closed
Net flow last quarter+$1.9MBuys minus sells
Top 10 positions weight18.2%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 8, 202674 positions | |||||
| $5.36M | 3.55% | 9.59% | +3.4% | Q4 2023 | |
| $3.7M | 2.45% | 0.00% | +11.4% | Q4 2023 | |
| $3.28M | 2.17% | Not reported | -9.5% | Q4 2023 | |
| $2.81M | 1.86% | Not reported | +4.0% | Q4 2023 | |
| PMPMLPimco Municipal Income Fund II | $2.58M | 1.70% | Not reported | -8.8% | Q3 2025 |
| $2.34M | 1.55% | Not reported | +17.3% | Q4 2023 | |
| $2M | 1.32% | 0.00% | +2.6% | Q3 2025 | |
| $1.98M | 1.31% | 0.01% | -5.1% | Q4 2023 | |
| $1.77M | 1.17% | 0.00% | +0.6% | Q4 2024 | |
| $1.74M | 1.15% | 0.00% | +1.1% | Q4 2023 | |
| $1.53M | 1.01% | 0.00% | +39.4% | Q4 2023 | |
| $1.47M | 0.97% | Not reported | Not reported | Q4 2023 | |
| $1.38M | 0.91% | Not reported | +1.7% | Q2 2024 | |
| $1.32M | 0.88% | 0.00% | +18.8% | Q4 2023 | |
| $1.25M | 0.83% | 0.00% | +4.1% | Q4 2023 | |
| $1.24M | 0.82% | 0.00% | -4.7% | Q4 2023 | |
| $1.24M | 0.82% | 0.00% | +11.2% | Q2 2024 | |
| $1.1M | 0.73% | Not reported | -0.9% | Q4 2023 | |
| $908K | 0.60% | 0.00% | +30.6% | Q4 2025 | |
| $887K | 0.59% | 0.00% | -1.7% | Q4 2023 | |
| $797K | 0.53% | 0.01% | -0.7% | Q4 2023 | |
| PBPMBSPuramed Bioscience Inc. | $781K | 0.52% | 0.01% | +229.6% | Q1 2026 |
| $744K | 0.49% | Not reported | Not reported | Q4 2023 | |
| $635K | 0.42% | 0.00% | Not reported | Q4 2023 | |
| $577K | 0.38% | Not reported | +32.6% | Q2 2024 | |
| $574K | 0.38% | Not reported | Not reported | Q4 2023 | |
| $507K | 0.34% | 0.00% | Not reported | Q2 2025 | |
| $459K | 0.30% | 0.00% | -1.0% | Q2 2024 | |
| $447K | 0.30% | 0.00% | Not reported | Q4 2023 | |
| $417K | 0.28% | 0.00% | +59.1% | Q4 2023 | |
| $416K | 0.28% | 0.00% | -4.1% | Q4 2023 | |
| $405K | 0.27% | 0.00% | +3.7% | Q1 2026 | |
| $379K | 0.25% | 0.00% | +0.4% | Q3 2024 | |
| $365K | 0.24% | 0.03% | -2.9% | Q2 2024 | |
| $327K | 0.22% | 0.00% | New | Q2 2026 | |
| $323K | 0.21% | 0.00% | +4.7% | Q4 2023 | |
| $306K | 0.20% | 0.01% | Not reported | Q4 2023 | |
| $283K | 0.19% | 0.00% | Not reported | Q2 2024 | |
| $277K | 0.18% | 0.00% | New | Q2 2026 | |
| $276K | 0.18% | 0.00% | New | Q2 2026 | |
| $223K | 0.15% | 0.00% | +4.7% | Q4 2025 | |
| $195K | 0.13% | 0.04% | -4.4% | Q1 2026 | |
| $189K | 0.12% | 0.07% | +28.8% | Q1 2026 | |
| $164K | 0.11% | 0.08% | +38.5% | Q2 2024 | |
| $163K | 0.11% | 0.11% | -0.4% | Q3 2025 | |
| $137K | 0.09% | Not reported | -0.1% | Q2 2024 | |
| $131K | 0.09% | 0.05% | -33.8% | Q1 2025 | |
| $129K | 0.09% | 0.46% | -22.6% | Q1 2026 | |
| $121K | 0.08% | 0.15% | +65.6% | Q1 2025 | |
| $107K | 0.07% | 0.07% | +56.9% | Q3 2025 | |
| Q1 2026Reported Apr 21, 202678 positions | |||||
| $6.25M | 4.68% | 9.26% | -4.0% | Q4 2023 | |
| $3.47M | 2.59% | Not reported | -3.5% | Q4 2023 | |
| $2.93M | 2.20% | 0.00% | +14.8% | Q4 2023 | |
| PMPMLPimco Municipal Income Fund II | $2.82M | 2.11% | Not reported | +9.3% | Q3 2025 |
| $2.66M | 1.99% | 0.01% | -40.4% | Q4 2023 | |
| $2.37M | 1.78% | Not reported | -2.2% | Q4 2023 | |
| $2.09M | 1.56% | 0.00% | Not reported | Q4 2024 | |
| $1.58M | 1.18% | Not reported | -32.6% | Q4 2023 | |
| $1.3M | 0.97% | Not reported | -10.2% | Q2 2024 | |
| $1.29M | 0.97% | 0.00% | -16.5% | Q4 2023 | |
| $1.15M | 0.86% | Not reported | Not reported | Q4 2023 | |
| $998K | 0.75% | 0.00% | +4.6% | Q4 2023 | |
| $985K | 0.74% | 0.00% | -19.8% | Q4 2023 | |
| $927K | 0.69% | Not reported | -0.3% | Q4 2023 | |
| $914K | 0.68% | 0.00% | +79.4% | Q4 2023 | |
| $881K | 0.66% | 0.00% | +2.7% | Q4 2023 | |
| $796K | 0.60% | 0.00% | +0.5% | Q2 2024 | |
| $755K | 0.56% | 0.00% | Not reported | Q4 2023 | |
| $721K | 0.54% | Not reported | -0.2% | Q4 2023 | |
| $670K | 0.50% | 0.01% | -29.6% | Q4 2023 | |
| $620K | 0.46% | 0.00% | +6.6% | Q3 2025 | |
| $611K | 0.46% | 0.00% | +86.9% | Q4 2025 | |
| $547K | 0.41% | Not reported | Not reported | Q4 2023 | |
| $531K | 0.40% | 0.00% | Not reported | Q4 2023 | |
| $487K | 0.36% | 0.00% | -4.4% | Q4 2023 | |
| $463K | 0.35% | 0.00% | -31.7% | Q4 2023 | |
| $447K | 0.33% | Not reported | -51.1% | Q2 2024 | |
| $419K | 0.31% | 0.00% | +9.9% | Q2 2024 | |
| $398K | 0.30% | 0.00% | -12.1% | Q3 2025 | |
| AMAVNSAvanos Medical, Inc. | $371K | 0.28% | 0.06% | -23.2% | Q1 2025 |
| $345K | 0.26% | 0.00% | New | Q1 2026 | |
| $345K | 0.26% | 0.00% | +0.6% | Q3 2024 | |
| $277K | 0.21% | Not reported | New | Q1 2026 | |
| $277K | 0.21% | 0.03% | +0.5% | Q2 2024 | |
| $259K | 0.19% | 0.00% | -5.9% | Q4 2023 | |
| $252K | 0.19% | 0.00% | Not reported | Q4 2023 | |
| $252K | 0.19% | 0.00% | -45.4% | Q1 2025 | |
| PBPMBSPuramed Bioscience Inc. | $237K | 0.18% | 0.00% | New | Q1 2026 |
| $212K | 0.16% | 0.00% | New | Q1 2026 | |
| $207K | 0.16% | 0.00% | New | Q1 2026 | |
| $205K | 0.15% | 0.00% | +4.5% | Q4 2025 | |
| $203K | 0.15% | 0.00% | +2.6% | Q4 2023 | |
| $194K | 0.15% | 0.02% | Not reported | Q4 2023 | |
| $175K | 0.13% | 0.05% | New | Q1 2026 | |
| $143K | 0.11% | 0.08% | +12.7% | Q1 2025 | |
| $141K | 0.11% | Not reported | +10.7% | Q2 2024 | |
| $141K | 0.11% | 0.11% | -25.1% | Q3 2025 | |
| $138K | 0.10% | 0.60% | New | Q1 2026 | |
| $137K | 0.10% | 0.04% | New | Q1 2026 | |
| $111K | 0.08% | 0.06% | +18.6% | Q2 2024 | |
| Q4 2025Reported Feb 5, 202675 positions | |||||
| $5.42M | 4.08% | 9.65% | -1.1% | Q4 2023 | |
| $4.22M | 3.18% | 0.01% | -4.7% | Q4 2023 | |
| $3.65M | 2.75% | Not reported | -8.5% | Q4 2023 | |
| $2.72M | 2.05% | 0.00% | +3.0% | Q4 2023 | |
| PMPMLPimco Municipal Income Fund II | $2.56M | 1.93% | Not reported | -17.5% | Q3 2025 |
| $2.53M | 1.90% | Not reported | +5.8% | Q4 2023 | |
| $2.47M | 1.86% | Not reported | +55.8% | Q4 2023 | |
| $2.03M | 1.53% | 0.00% | +31.5% | Q4 2023 | |
| $1.52M | 1.14% | Not reported | -0.4% | Q2 2024 | |
| $1.35M | 1.01% | 0.00% | +11.5% | Q4 2023 | |
| $1.05M | 0.79% | 0.00% | +9.4% | Q4 2023 | |
| $1.05M | 0.79% | Not reported | -4.0% | Q4 2023 | |
| $1.04M | 0.78% | Not reported | +63.9% | Q2 2024 | |
| $989K | 0.74% | Not reported | +1.6% | Q4 2023 | |
| $705K | 0.53% | 0.00% | +30.9% | Q2 2024 | |
| $702K | 0.53% | Not reported | -1.3% | Q4 2023 | |
| $683K | 0.51% | 0.00% | Not reported | Q4 2023 | |
| $667K | 0.50% | 0.00% | New | Q4 2025 | |
| $661K | 0.50% | 0.00% | +3.0% | Q4 2023 | |
| $586K | 0.44% | 0.00% | -10.0% | Q4 2023 | |
| $570K | 0.43% | 0.01% | -10.5% | Q4 2023 | |
| $536K | 0.40% | 0.00% | +54.1% | Q4 2023 | |
| $532K | 0.40% | Not reported | Not reported | Q4 2023 | |
| $483K | 0.36% | 0.00% | -29.7% | Q2 2025 | |
| $481K | 0.36% | 0.00% | -17.5% | Q4 2023 | |
| $451K | 0.34% | 0.00% | +2.3% | Q3 2025 | |
| $434K | 0.33% | 0.00% | +26.2% | Q1 2025 | |
| $433K | 0.33% | 0.00% | -0.6% | Q4 2023 | |
| $416K | 0.31% | 0.00% | +7.6% | Q2 2024 | |
| $397K | 0.30% | 0.03% | -3.3% | Q2 2024 | |
| $392K | 0.29% | 0.00% | -5.2% | Q3 2025 | |
| AMAVNSAvanos Medical, Inc. | $385K | 0.29% | 0.07% | +1.9% | Q1 2025 |
| $347K | 0.26% | 0.00% | New | Q4 2025 | |
| $259K | 0.20% | 0.15% | +66.0% | Q3 2025 | |
| $258K | 0.19% | 0.00% | Not reported | Q3 2024 | |
| $255K | 0.19% | 0.00% | -2.9% | Q4 2023 | |
| $248K | 0.19% | 0.02% | Not reported | Q4 2023 | |
| $238K | 0.18% | 0.00% | +4.3% | Q4 2023 | |
| $233K | 0.18% | 0.00% | -14.5% | Q2 2025 | |
| $225K | 0.17% | 0.00% | Not reported | Q2 2024 | |
| $222K | 0.17% | 0.00% | -19.1% | Q4 2024 | |
| $202K | 0.15% | 0.05% | -10.7% | Q4 2023 | |
| $201K | 0.15% | 0.00% | New | Q4 2025 | |
| $156K | 0.12% | 0.03% | -2.4% | Q4 2023 | |
| $143K | 0.11% | 0.07% | +106.8% | Q1 2025 | |
| $141K | 0.11% | 0.05% | -3.4% | Q2 2024 | |
| $136K | 0.10% | 0.10% | +30.9% | Q3 2025 | |
| $116K | 0.09% | 0.02% | -12.6% | Q1 2025 | |
| $115K | 0.09% | 0.11% | +97.1% | Q1 2025 | |
| $115K | 0.09% | 0.11% | New | Q4 2025 | |
| Q3 2025Reported Oct 30, 202572 positions | |||||
| $4.79M | 3.68% | 9.75% | -0.4% | Q4 2023 | |
| $3.99M | 3.07% | Not reported | +58.3% | Q4 2023 | |
| PMPMLPimco Municipal Income Fund II | $3.25M | 2.50% | Not reported | New | Q3 2025 |
| $2.92M | 2.24% | 0.01% | -2.0% | Q4 2023 | |
| $2.47M | 1.90% | 0.00% | +2.6% | Q4 2023 | |
| $2.33M | 1.79% | Not reported | -0.1% | Q4 2023 | |
| $1.65M | 1.27% | 0.00% | +24.5% | Q4 2023 | |
| $1.55M | 1.19% | Not reported | +7.7% | Q4 2023 | |
| $1.53M | 1.17% | Not reported | +1.4% | Q2 2024 | |
| $1.15M | 0.88% | 0.00% | -8.6% | Q4 2023 | |
| $1.01M | 0.78% | Not reported | -3.3% | Q4 2023 | |
| $918K | 0.71% | 0.00% | +0.5% | Q4 2023 | |
| $756K | 0.58% | Not reported | -1.8% | Q4 2023 | |
| $707K | 0.54% | Not reported | +2.6% | Q2 2024 | |
| $704K | 0.54% | Not reported | -0.6% | Q4 2023 | |
| $698K | 0.54% | 0.00% | +45.3% | Q4 2023 | |
| $678K | 0.52% | 0.01% | -5.1% | Q4 2023 | |
| $669K | 0.51% | 0.00% | -2.5% | Q2 2025 | |
| $613K | 0.47% | 0.00% | Not reported | Q4 2023 | |
| $582K | 0.45% | 0.00% | New | Q3 2025 | |
| $574K | 0.44% | 0.00% | New | Q3 2025 | |
| $523K | 0.40% | 0.00% | Not reported | Q4 2023 | |
| $517K | 0.40% | Not reported | Not reported | Q4 2023 | |
| $502K | 0.39% | 0.00% | Not reported | Q4 2023 | |
| $495K | 0.38% | 0.00% | -64.9% | Q2 2024 | |
| $466K | 0.36% | 0.00% | New | Q3 2025 | |
| $445K | 0.34% | 0.00% | +21.6% | Q2 2025 | |
| $405K | 0.31% | 0.00% | New | Q3 2025 | |
| $405K | 0.31% | 0.03% | +21.9% | Q2 2024 | |
| AMAVNSAvanos Medical, Inc. | $389K | 0.30% | 0.07% | +51.6% | Q1 2025 |
| $388K | 0.30% | 0.00% | +18.9% | Q2 2025 | |
| $388K | 0.30% | 0.00% | New | Q3 2025 | |
| $382K | 0.29% | 0.00% | +2.1% | Q1 2025 | |
| $378K | 0.29% | 0.00% | +0.5% | Q2 2024 | |
| $313K | 0.24% | 0.00% | -6.1% | Q4 2023 | |
| $297K | 0.23% | 0.01% | -14.0% | Q1 2025 | |
| $294K | 0.23% | 0.00% | -65.5% | Q2 2025 | |
| $277K | 0.21% | 0.00% | Not reported | Q4 2024 | |
| $270K | 0.21% | 0.00% | Not reported | Q4 2023 | |
| SSEMRSemrush Holdings, Inc. | $264K | 0.20% | 0.16% | New | Q3 2025 |
| $259K | 0.20% | 0.00% | New | Q3 2025 | |
| $239K | 0.18% | 0.00% | -52.0% | Q4 2023 | |
| $235K | 0.18% | 0.00% | Not reported | Q3 2024 | |
| $226K | 0.17% | 0.00% | -12.9% | Q4 2023 | |
| $163K | 0.13% | 0.06% | -0.3% | Q4 2023 | |
| $157K | 0.12% | 0.07% | -19.9% | Q3 2024 | |
| $156K | 0.12% | 0.09% | New | Q3 2025 | |
| $147K | 0.11% | 0.02% | Not reported | Q4 2023 | |
| $145K | 0.11% | 0.05% | -5.3% | Q2 2024 | |
| $139K | 0.11% | 0.03% | Not reported | Q4 2023 | |
Premium opens every quarter this fund has filed